{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:32:10Z","timestamp":1777577530242,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.molimm.2023.09.014","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:30:20Z","timestamp":1695997820000},"page":"136-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites"],"prefix":"10.1016","volume":"163","author":[{"given":"Rajan","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshul","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishakhi","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.09.014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106826","article-title":"Leishmania donovani induces CD300a expression to dampen effector properties of CD11c(+) dendritic and antigen activated CD8(+) T cells","volume":"239","author":"Anand","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2023.09.014_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Bacellar","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.molimm.2023.09.014_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri2379","article-title":"T-cell activation by dendritic cells in the lymph node: lessons from the movies","volume":"8","author":"Bousso","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib4","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.09.014_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin. Trans. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib6","first-page":"8","article-title":"Anti-Pd-1 and Anti-Pd-L1 antibodies as immunotherapy against cancer: a structural perspective","volume":"73","author":"Cordova-Bahena","year":"2021","journal-title":"Rev. Invest Clin."},{"key":"10.1016\/j.molimm.2023.09.014_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","article-title":"Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics","volume":"7","author":"Davda","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.molimm.2023.09.014_bib8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib9","doi-asserted-by":"crossref","first-page":"3967436","DOI":"10.1155\/2016\/3967436","article-title":"Dendritic cells and Leishmania infection: adding layers of complexity to a complex disease","volume":"2016","author":"Feijo","year":"2016","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.molimm.2023.09.014_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.molimm.2023.09.014_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.2009.80.345","article-title":"Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India","volume":"80","author":"Gidwani","year":"2009","journal-title":"Am. J. Trop. Med Hyg."},{"key":"10.1016\/j.molimm.2023.09.014_bib12","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.09.014_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.molimm.2023.09.014_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.20092017","article-title":"Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection","volume":"207","author":"Kim","year":"2010","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2023.09.014_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.2010.09-0341","article-title":"Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine","volume":"82","author":"Kumar","year":"2010","journal-title":"Am. J. Trop. Med Hyg."},{"key":"10.1016\/j.molimm.2023.09.014_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcimb.2012.00083","article-title":"The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response","volume":"2","author":"Liu","year":"2012","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.molimm.2023.09.014_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"227","key":"10.1016\/j.molimm.2023.09.014_bib20","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200","volume":"7","author":"Mahadevan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.molimm.2023.09.014_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00285-8","article-title":"New threats to visceral leishmaniasis control","volume":"2","author":"Makoni","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.molimm.2023.09.014_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molimm.2023.09.014_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment","volume":"107","author":"McGwire","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.molimm.2023.09.014_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int J. Prev. Med"},{"key":"10.1016\/j.molimm.2023.09.014_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2023.09.014_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.it.2006.04.006","article-title":"Committed to memory: lineage choices for activated T cells","volume":"27","author":"Moulton","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1674-8301(10)60004-8","article-title":"A review of adjuvants for Leishmania vaccine candidates","volume":"24","author":"Mutiso","year":"2010","journal-title":"J. Biomed. Res"},{"key":"10.1016\/j.molimm.2023.09.014_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1674-8301(12)60002-5","article-title":"Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops)","volume":"26","author":"Mutiso","year":"2012","journal-title":"J. Biomed. Res"},{"key":"10.1016\/j.molimm.2023.09.014_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.09.014_bib30","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.4049\/jimmunol.180.12.8299","article-title":"The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma","volume":"180","author":"Pakpour","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.molimm.2023.09.014_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjh.17125","article-title":"Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo","volume":"193","author":"Rastogi","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2023.09.014_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijbiomac.2020.02.189","article-title":"The CD200-CD200R cross-talk helps Leishmania donovani to down regulate macrophage and CD4(+)CD44(+) T cells effector functions in an NFkappaB independent manner","volume":"151","author":"Rawat","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.molimm.2023.09.014_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.molimm.2023.09.014_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773983","article-title":"Multifunctional, TNF-alpha and IFN-gamma-secreting CD4 and CD8 T cells and CD8(High) T cells are associated with the cure of human visceral leishmaniasis","volume":"12","author":"Rodrigues","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002567","article-title":"Impairment of T cell function in parasitic infections","volume":"8","author":"Rodrigues","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.09.014_bib38","first-page":"160","article-title":"Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice","volume":"50","author":"Rostamian","year":"2017","journal-title":"J. Microbiol Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2023.09.014_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","article-title":"The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development","volume":"201","author":"Scott","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2023.09.014_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib42","article-title":"CD300a receptor blocking enhances early clearance of leishmania donovani from its mammalian host through modulation of effector functions of phagocytic and antigen experienced T cells","volume":"12","author":"Singh","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib43","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2018.01176","article-title":"Centrin-deleted leishmania donovani parasites help CD4(+) T cells to acquire Th1 phenotype and multi-functionality through downregulation of CD200-CD200R immune inhibitory axis","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib44","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.4049\/jimmunol.165.6.3136","article-title":"Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo","volume":"165","author":"Smith","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib45","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.180.7.4355","article-title":"Modulation of dendritic cell function by Leishmania parasites","volume":"180","author":"Soong","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"Sp\u00e4th","year":"2001","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.molimm.2023.09.014_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.molimm.2023.09.014_bib48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41573-021-00259-5","article-title":"Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies","volume":"21","author":"Sullivan","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molimm.2023.09.014_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fimmu.2019.00227","article-title":"Molecular aspects of dendritic cell activation in leishmaniasis: an immunobiological view","volume":"10","author":"Tiburcio","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2023.09.014_bib51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"Velez","year":"2005","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"key":"10.1016\/j.molimm.2023.09.014_bib52","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.molimm.2023.09.014_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.exppara.2007.04.004","article-title":"Leishmania donovani: Inhibition of phagosomal maturation is rescued by nitric oxide in macrophages","volume":"117","author":"Winberg","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.molimm.2023.09.014_bib54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/cam4.4905","article-title":"Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia","volume":"12","author":"Xu","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.molimm.2023.09.014_bib55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fcimb.2019.00228","article-title":"Biomarkers in Post-kala-azar Dermal Leishmaniasis","volume":"9","author":"Zijlstra","year":"2019","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.molimm.2023.09.014_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: a threat to the South-East Asia Region Kala-azar Elimination Programme","volume":"11","author":"Zijlstra","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.09.014_bib57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/vaccines7040156","article-title":"Anti-Leishmanial vaccines: assumptions, approaches, and annulments","volume":"7","author":"Zutshi","year":"2019","journal-title":"Vaccines"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:47:51Z","timestamp":1758980871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":57,"alternative-id":["S0161589023001955"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.09.014","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}